Elias Jackson Jr., Ph.D.
Director of Government and Scientific Affairs
Vyripharm Enterprises, Inc.
Elias leads a group that includes government affairs, scientific affairs and policy. He oversees the company’s initiative to promote and enhance public health and public safety through strategic communications, U.S. Policy and Federal Government Relations.
Elias has a broad background in molecular and cellular biology, immunological mechanisms, and imaging. His research projects and collaborations are focused on the integration of traditional pharmaceuticals with non-traditional pharmaceuticals to have a high impact on the standard of treatment for various diseases.
Prior to joining Vyripharm, Elias served as Associate Professor of Physiology at American University of Antigua College of Medicine and Research Scientist at Yale School of Medicine Cardiovascular Center. He was previously involved with drug development at ILEX Oncology.
Elias received his B.S. in biology from The University of Texas at San Antonio. He earned his doctoral degree at UTMB in cell biology under the mentorship of Dr. Sankar Mitra and Dr. Satish Srivastava. Elias completed his postdoctoral training at Yale University School of Medicine Cardiovascular Research Center.
